Electrocompetent Cells is fastest growing segment fueling the growth of Electrocompetent Cells market

 

The global Electrocompetent Cells Market is estimated to be valued at US$ 2.07 Bn in 2023 and is expected to exhibit a CAGR of 10. % over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Electrocompetent cells are bacterial strains that are able to take up exogenous DNA from their external environment after being subjected to an electric pulse (electroporation). They are useful in applications requiring transformation of an organism by introduction of foreign DNA.

Market key trends:
One of the key trends in the electrocompetent cells market is the increasing prevalence of genetic disorders globally. As per data by the WHO, around 300 million people are affected by genetic disorders worldwide. These disorders can be treated by techniques involving transfer of genetic material into competent cells. For instance, gene therapy involves transferring a normal gene into a patient's cells instead of the defective one causing the genetic disorder. This drives the demand for electrocompetent cells for cloning and propagation of vectors and plasmids used in gene therapy treatments.
Segment Analysis
The global electrocompetent cells market is segmented into kits and reagents, cells, instruments, and services. The kits and reagents segment dominated the market in 2022 and is expected to continue its dominance over the forecast period owing to wide usage of kits and reagents in various cloning and transfection experiments. Kits and reagents provide researchers with all the necessary components required for transformation of DNA into competent cells in a ready-to-use format, which drives their high demand.

Key Takeaways
The global electrocompetent cells market is expected to witness high growth, exhibiting a CAGR of 10% over the forecast period, due to increasing R&D investments in genomics and DNA cloning. The global electrocompetent cells market size is expected to reach US$ 2.07 Bn by 2023.

Regional analysis - North America dominates the global electrocompetent cells market currently and is expected to continue its dominance over the forecast period. This is attributed to presence of major players and advanced research infrastructure for life sciences in the region. Asia Pacific is expected to exhibit highest growth rate owing to increasing government initiatives to promote genomics research and growing pharmaceutical industry.

Key players - Key players operating in the electrocompetent cells market are Thermo Fisher Scientific Inc., Merck KGaA, Agilent Technologies, Inc., QIAGEN N.V., New England Biolabs, Inc., GenScript Biotech Corporation, Lucigen Corporation, Takara Bio Inc., Delphi Genetics S.A., IBA GmbH, Scarab Genomics LLC, Zymo Research Corporation, Bioline GmbH (Meridian Bioscience), SelectScience, and Biosearch Technology. The major players are focusing on new product launches and collaborations to expand their product portfolio and market share.

Comments

Post a Comment

Popular posts from this blog

Unveiling Health Secrets: Exploring the Potential of Blood-Based Biomarkers

Image
  The human body is a complex and intricate system, often harboring subtle signs of its inner workings. One of the most promising avenues for unlocking these secrets lies within our bloodstream – a treasure trove of information encoded in the form of blood-based biomarkers. These biomarkers, measurable indicators present in the blood, hold the potential to revolutionize healthcare by providing early detection, accurate diagnosis, and personalized treatment approaches. Blood-based biomarkers encompass a wide range of molecules – from proteins and nucleic acids to metabolites and even circulating cells. Researchers have been diligently working to identify specific biomarkers associated with various diseases and conditions. For instance, elevated levels of certain proteins might point to cardiovascular diseases, while specific genetic material could indicate the presence of cancer. By analyzing these biomarkers, clinicians gain valuable insights into an individual's health status, en...
Read more

Revolutionizing Biology: Advancements in Single Cell Analysis Techniques

Image
  Single cell analysis has emerged as a groundbreaking technology that is revolutionizing the field of biology. Traditionally, biological studies were conducted on populations of cells, averaging out the heterogeneity present within them. However, the advent of single cell analysis has enabled scientists to delve into the complexity of individual cells, uncovering a wealth of previously inaccessible information. Advancements in single cell analysis techniques have paved the way for a deeper understanding of cellular heterogeneity, gene expression, and cellular behavior. One of the most remarkable techniques is single-cell RNA sequencing (scRNA-seq), which allows scientists to measure gene expression in individual cells. This breakthrough has led to the identification of rare cell types, understanding of cellular communication networks, and the discovery of novel biomarkers. Moreover, single cell imaging techniques, such as single cell fluorescence microscopy, have enabled research...
Read more

Medical Robots Market Poised to Grow Owing to Improving Healthcare Infrastructure

Image
 The Medical Robots Market is anticipated to witness robust growth due to rising healthcare spending across the globe. Medical robots are used to perform minimal invasive surgeries with greater accuracy and flexibility. Growing preference for Robot-Assisted Surgery (RAS) over conventional open surgeries due to benefits such as shorter recovery time and minimum operative scars has been augmenting demand for medical robots. Key functions include guiding and positioning surgical accessories like guide tubes in radiology and guiding catheter and wires in cardiology. With rising chronic disease prevalence associated with aging populations, the need for more surgical procedures is surging which requires precise action minimally invasive robotic systems can provide. The Global Medical Robots Market is estimated to be valued at US$ 11.47 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2023 to 2030. Key Takeaways: Key players operating in the Medical Robo...
Read more